CARLSMED, INC. Plans $100 Million IPO for July 23rd (CARL)

CARLSMED, INC. (CARL) plans to raise $100 million in an IPO on Wednesday, July 23rd, IPO Scoop reports. The company will issue 6,700,000 shares at $14.00-$16.00 per share.

In the last 12 months, CARLSMED, INC. generated $32.3 million in revenue and had a net loss of $25.1 million. The company has a market-cap of $397.7 million.

Carlsmed, Inc. provided the following description of their company for its IPO: “We provide implants, surgical instruments and AI-enabled software for spine fusion surgery.  We are currently focused on lumbar spine surgery. Our aprevo technology platform consists of AI-enabled software solutions, interbody implants custom designed for each patient and single-use surgical instruments. Note: Net loss and revenue are for the 12 months that ended March 31, 2025.    (Note: Carlsmed, Inc. disclosed its IPO’s terms in its S-1/A filing on July 15, 2025, as follows: Carlsmed is offering 6.7 million shares at a price range of $14.00 to $16.00 to raise $100.5 million, if priced at the $15.00 mid-point of its range. Background: Carlsmed, Inc. filed its S-1 to go public on June 26, 2025, without disclosing the terms for its IPO. Estimated initial IPO proceeds were $100 million, a placeholder figure.)   “.

Carlsmed, Inc. was founded in 2018 and has 100 employees. The company is located at 1800 Aston Ave, Suite 100 Carlsbad, California 92008 and can be reached via phone at (760) 766-1923 or on the web at https://www.carlsmed.com./.